1228557-26-3 Usage
General Description
"(1R)-1-(5-Bromo-2-fluorophenyl)ethylamine" is a chemical compound with the molecular formula C8H10BrFN. It is an organic compound that contains a primary amine functional group, and it is commonly used in the pharmaceutical and research industries. (1R)-1-(5-BROMO-2-FLUOROPHENYL)ETHYLAMINE has applications in medicinal chemistry and drug discovery, where it can be used as a building block in the synthesis of various pharmaceutical compounds. The presence of the bromine and fluorine atoms in the molecule gives it unique properties that make it useful in the development of new drugs and biologically active molecules. Additionally, its chiral nature, indicated by the (1R) designation, means that it exists in two mirror-image forms, or enantiomers, which can have different biological activities. Overall, "(1R)-1-(5-Bromo-2-fluorophenyl)ethylamine" is a versatile chemical that plays a valuable role in the development of new pharmaceuticals and research compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1228557-26-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,5,5 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1228557-26:
(9*1)+(8*2)+(7*2)+(6*8)+(5*5)+(4*5)+(3*7)+(2*2)+(1*6)=163
163 % 10 = 3
So 1228557-26-3 is a valid CAS Registry Number.
1228557-26-3Relevant articles and documents
NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS
-
Paragraph 0532-0535, (2018/10/30)
The invention relates inter alia to compounds of the general formula (I). Also described are methods for preparing the compounds of the formula (I). The compounds according to the invention are especially suitable for controlling insects, arachnids and ne
HETEROCYCLIC INHIBITORS OF GLUTAMINASE
-
Page/Page column 143, (2013/06/06)
The invention relates to the heterocyclic compounds of Formula (I) as defined further herein, and pharmaceutical preparations thereof. The invention further relates to methods of treating cancer, immunological or neurological diseases using the heterocyclic compounds of the invention.
